Search

Your search keyword '"Marek Pertkiewicz"' showing total 6 results
Start Over Author "Marek Pertkiewicz" Publisher ovid technologies (wolters kluwer health)
6 results on '"Marek Pertkiewicz"'

1. Long-term Safety and Efficacy of Teduglutide for the Treatment of Intestinal Failure Associated with Short Bowel Syndrome: Final Results of the STEPS-2 Study, a 2-year, Multicenter, Open-label Clinical Trial

Author

Lauren K. Schwartz, Nader N. Youssef, Marek Pertkiewicz, Ken Fujioka, Palle Jeppesen, and Stephen OʼKeefe

Subjects
Pediatrics, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Short bowel syndrome, medicine.disease, Teduglutide, Clinical trial, chemistry.chemical_compound, chemistry, Intestinal failure, medicine, Long term safety, Open label, business
Published
2013

2. Treatment Out to 1 Year with a GLP-2 Analog, Teduglutide, Safely Reduces Parenteral Nutrition (PN) Needs in PN-Dependent Short Bowel Syndrome (SBS) Patients

Author

Khursheed N. Jeejeebhoy, Douglas L. Seidner, Lyn Howard, Nancy McGraw, Richard Gilroy, Palle Jeppesen, Bernard Messing, Stephen OʼKeefe, Marek Pertkiewicz, and Johane P. Allard

Subjects
GLP-2 Analog, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Short bowel syndrome, medicine.disease, Teduglutide, chemistry.chemical_compound, Parenteral nutrition, chemistry, Internal medicine, medicine, business
Published
2008

3. Teduglutide (TED) for the Treatment of Short Bowel Syndrome-Intestinal Failure (SBS-IF) Subjects Yields Further Reductions in Parenteral Support (PS): An Interim Assessment of a 2-Year, Open-label, Phase 3 Trial (STEPS2)

Author

Hartmut Heinze, Marek Pertkiewicz, Lauren K. Schwartz, Douglas L. Seidner, Palle Jeppesen, and Nader N. Youssef

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Short bowel syndrome, medicine.disease, Teduglutide, chemistry.chemical_compound, chemistry, Internal medicine, Interim, Intestinal failure, medicine, Open label, business
Published
2011

4. Teduglutide, A Novel Analog of Glucagon-like Peptide 2 (GLP-2), Is Effective and Well Tolerated in Reducing Parenteral Support (PS) Volume in Short Bowel Syndrome-Intestinal Failure (SBS-IF) Subjects: Results from a 24-week, Placebo-Controlled Phase 3 Trial

Author

Bo Joelsson, Stephen OʼKeefe, Hartmut Heinze, Marek Pertkiewicz, Douglas L. Seidner, and Palle Jeppesen

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Glucagon-like peptide-2, Placebo, Short bowel syndrome, medicine.disease, Teduglutide, chemistry.chemical_compound, chemistry, Internal medicine, Intestinal failure, Medicine, business
Published
2011

5. The Fluid Composite Effect (FCE): A Clinically Important Surrogate Measure of Intestinal Absorption in Adult Subjects with Short Bowel Syndrome (SBS)-Intestinal Failure (IF) Dependent on Parenteral Support (PS) Being Treated with Teduglutide

Author

Peter Berghoefer, Marek Pertkiewicz, Bo Joelsson, Kenneth Fujioka, Palle Jeppesen, and Joseph I. Boullata

Subjects
medicine.medical_specialty, Hepatology, business.industry, Surrogate measure, Gastroenterology, Short bowel syndrome, medicine.disease, Teduglutide, Intestinal absorption, chemistry.chemical_compound, chemistry, Intestinal failure, Internal medicine, medicine, Composite effect, business
Published
2011

6. Teduglutide, a GLP-2 Analog Enhances Intestinal Structure in Short Bowel Syndrome (SBS) Patients Dependent on Parenteral Nutrition (PN)

Author

Johane P. Allard, M. Kunecki, Richard Gilroy, Palle Jeppesen, Marek Pertkiewicz, Kelly A. Tappenden, Hans Sauerwein, Nancy McGraw, and Bernard Messing

Subjects
GLP-2 Analog, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Short bowel syndrome, medicine.disease, Teduglutide, chemistry.chemical_compound, Parenteral nutrition, chemistry, Internal medicine, medicine, Intestinal structure, business
Published
2008

Catalog

Books, media, physical & digital resources
See catalog results